glp-1 news october 21 2025 Alarming rise in weight loss drug overdoses GLP-1 Pipeline Update: November 2025

Ozempic, Wegovy and Mounjaro accounted for nearly $4-billion in sales at retail pharmacies in 2025, according to IQVIA Canada

Mounjaro is a newer option that targets two hormones and can be discussed with healthcare providers for suitable treatment plans

Limited head-to-head studies compare established glucagon-like peptide-1 receptor agonists (GLP-1 RAs), dipeptidyl peptidase-4 inhibitors (DPP-4is), and sodium-glucose co-transporter-2 inhibitors (SGLT-2is) to insulin in the management of uncontrolled type 2 diabetes mellitus (T2DM)

Accessing cheaper weight loss drugs involves compounding pharmacies, savings coupons, or cash-pay programs for people who cannot afford them.

Learn more and see if you should add it to your stac

November 1, 2023